Related Experiment Videos
Modulation of insulin activities by leptin
B Cohen1, D Novick, M Rubinstein
1Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot 76100, Israel. lvrub@weizmann.weizmann.ac.il
Summary
Leptin, a hormone regulating appetite, may impact insulin signaling in the liver. This study found leptin can alter insulin-induced activities in human liver cells, suggesting a role in obesity.
Area of Science:
- Endocrinology
- Metabolism
- Molecular Biology
Background:
- Leptin is primarily known for regulating food intake via its hypothalamic receptor (OB-R).
- OB-R variants exist in other tissues, but their functions remain largely uncharacterized.
- Obesity is associated with altered leptin levels and insulin resistance.
Purpose of the Study:
- To investigate the function of an OB-R variant in human hepatic (liver) cells.
- To determine if leptin affects insulin signaling pathways in the liver.
- To explore the potential role of hepatic leptin signaling in obesity-related metabolic dysfunction.
Main Methods:
- Cultured human hepatic cells were exposed to leptin at concentrations relevant to obese individuals.
- Insulin-induced signaling events were measured, including insulin receptor substrate-1 (IRS-1) tyrosine phosphorylation and its association with growth factor receptor-bound protein 2 (Grb2).
- The activity of IRS-1-associated phosphatidylinositol 3-kinase (PI3K) and the regulation of gluconeogenesis were assessed.
Main Results:
- Leptin exposure attenuated several insulin-induced activities in hepatic cells.
- Specifically, leptin reduced IRS-1 tyrosine phosphorylation and the association of Grb2 with IRS-1.
- Leptin also led to the down-regulation of gluconeogenesis but increased the activity of IRS-1-associated PI3K.
Conclusions:
- A functional OB-R variant is present in human hepatic cells.
- Leptin can modulate key insulin signaling pathways in the liver, including those involved in glucose metabolism.
- These findings suggest that leptin may play a role in altering insulin sensitivity in obese individuals through hepatic mechanisms.